Enhancement in rats by the liver tumor promoter ethinyl estradiol of a serum factor(s) which is stimulatory for hepatocyte DNA synthesis.
Fractionation of female rat serum or plasma on Sephadex G-200 revealed the presence of an activity stimulatory for hepatocyte DNA synthesis. Treatment of female rats with the liver tumor promoter ethinyl estradiol (EE) at 2.5 micrograms/day caused a 1.6 fold increase in the level of this activity at 24 hr in both serum and plasma. The stimulatory activity had a molecular weight of 135 kD, was sensitive to trypsin and heating and was not inhibited by the antiestrogen tamoxifen or antibody to epidermal growth factor (EGF). However, the pooled active fractions from EE-treated rats competed to a greater extent than comparable fractions from control rats for specific [125I]-EGF binding to rat liver membranes. These results demonstrate that treatment of female rats with EE, under conditions known to stimulate liver growth, caused an increase in level of a factor(s) stimulatory for hepatocyte DNA synthesis and whose activity may be mediated through the EGF receptor.
Shi
Y E
YE
Department of Biochemistry, Dartmouth Medical School, Hanover, NH 03756.
Yager
J D
JD
D000818:Animals; D001667:Binding, Competitive; D002462:Cell Membrane / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis*; D004815:Epidermal Growth Factor / Q000276:immunology / Q000378:metabolism; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005260:Female; D006133:Growth Substances / Q000097:blood* / Q000494:pharmacology; D006358:Hot Temperature; D007106:Immune Sera / Q000494:pharmacology; D008099:Liver / Q000378:metabolism*; D008970:Molecular Weight; D051381:Rats; D011917:Rats, Inbred Lew; D013629:Tamoxifen / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology
D006133:Growth Substances; D007106:Immune Sera; D013629:Tamoxifen; D004997:Ethinyl Estradiol; D004815:Epidermal Growth Factor; D004247:DNA; D014357:Trypsin